Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02212639

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:51.989247+00:00

Published At

2018-07-23T00:00:00+00:00

Record Updated At

2018-07-23

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Kaposi\u0027 s Sarcoma", "Classic Kaposi\u0027 s Sarcoma", "Endemic Kaposi\u0027 s Sarcoma", "Lymph Angio Proliferations"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-07-23"

protocolSection.identificationModule.nctId

"NCT02212639"

protocolSection.identificationModule.officialTitle

"Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi\u0027 s Sarcoma"

protocolSection.statusModule.overallStatus

"UNKNOWN"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Kaposi' s Sarcoma (protocolSection.conditionsModule.conditions)
• Classic Kaposi' s Sarcoma (protocolSection.conditionsModule.conditions)
• Endemic Kaposi' s Sarcoma (protocolSection.conditionsModule.conditions)
• Lymph Angio Proliferations (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.